KCT0008183
Recruiting
未知
Effectiveness verification of Mirtazapine in Patients with Acute Anxiety
Chung-Ang Univerisity Hospital0 sites52 target enrollmentTBD
ConditionsMental and behavioural disorders
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Mental and behavioural disorders
- Sponsor
- Chung-Ang Univerisity Hospital
- Enrollment
- 52
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? The age of 18 to 65
- •? A person diagnosed as a major depressive disorder without psychotic features. by Structured Clinical Interview for DSM\-5 (SCID\-5\)
- •? BAI scale score is 16 or higher (with moderate or higher anxiety symptoms)
- •? Those who have no history of using Mirtazapine in the last two months based on the initial evaluation point
- •? Those who have been administering antidepressants (SSRI, SNRI and NDRI) at stable doses for more than 1 month
Exclusion Criteria
- •? A person who has been diagnosed other psychiatric diagnosis by SCID\-5\-CV in the past
- •? Those who currently have severe medical conditions (cancer, heart failure, kidney failure, liver disease, lung disease, thyroid disease and acute inflammatory conditions)
- •? A person who has a history of past or present dependence on substances or misuse
- •? A person with a history of epilepsy, head trauma, and organic mental illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
The effectiveness of mirtazapine in reducing dependence and the temptation to consume amphetamine and methamphetamine in patientsIRCT20230606058397N1Ahvaz University of Medical Sciences84
Not yet recruiting
Phase 3
Comparison of shivering in drugs of Mirtazapine , Dexamethasone and Tramadol after spinal anaesthesiaHealth Condition 1: O82- Encounter for cesarean delivery without indicationCTRI/2023/12/060608SRINIVASAN T
Recruiting
Phase 3
Effect of Mirtazapine on the quality of life of the breast cancer patientsIRCT20210425051075N1Sabzevar University of Medical Sciences110
Completed
Phase 3
Effect of topical mirtazapine on eczemaAtopic dermatitis.Other atopic dermatitisIRCT2015071722965N3Vice chancellor for research, Hamadan University of Medical Sciences120
Completed
Not Applicable
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phaseISRCTN00721331Stanley Medical Research Institute (USA)40